In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…
BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far more quietly than many people realise. Early indicators…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million…
ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Abu Dhabi Finance Week (ADFW) 2025 opened today with some of the…
At Goalkeepers Abu Dhabi, global leaders outline a path to improve and save the lives of millions of children through…
AUSTIN, Texas, Dec. 8, 2025 /PRNewswire/ -- Abracon, a leading provider of timing, frequency control, power, magnetics, RF, and antenna solutions,…
NORWALK, Conn., Dec. 8, 2025 /PRNewswire/ -- GameChange BOS, a division of GameChange Energy, announced that it has surpassed orders for…
Holistic system-technology co-optimization (STCO) approach key in reducing peak GPU and HBM temperatures under AI workloads while enhancing performance density…
Reference is made to the private placement (the "Private Placement") and the retail offering through PrimaryBid announced by Zelluna ASA on…